23,036,271
Vote Records
25,695
Companies
11,771
Funds
3,902
Managers

Home › Companies › CLOVER HEALTH INVESTMENTS CORP. › 2023-2024

CLOVER HEALTH INVESTMENTS CORP. 2023-2024 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and CLOVER HEALTH INVESTMENTS CORP.’s Form 8-K, filed June 13, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 5Ballot items
  • 96Asset managers, any item
  • 267Fund votes
  • June 10, 2024Meeting date

Results at a glance

Meeting of June 10, 2024: 5 items on CLOVER HEALTH INVESTMENTS CORP.’s Form 8-K, filed June 13, 2024: 3 elected · 1 approved · 1 passed (calculated).

Dissent

No notable dissent.

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore CLOVER HEALTH INVESTMENTS CORP. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by CLOVER HEALTH INVESTMENTS CORP.

These tallies are CLOVER HEALTH INVESTMENTS CORP.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 13, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

CLOVER HEALTH INVESTMENTS CORP. — official shareholder meeting results, meeting held June 10, 2024
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Chelsea Clinton 937,120,902---- 26,227,596145,211,573 97%Elected—
Elect Director: Carladenise Armbrister Edwards 942,172,343---- 21,176,155145,211,573 98%Elected—
Elect Director: Vivek Garipalli 941,392,586---- 21,955,912145,211,573 98%Elected—
2. Non-binding advisory vote to approve the compensation of the Company's Named Executive Officers for 2023 950,591,27210,963,4601,793,766 --145,211,573 99%Passed (calculated)—
3. Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2024 1,100,958,5125,333,7012,267,858 ---- 99.5%Approved—

Source: CLOVER HEALTH INVESTMENTS CORP., Form 8-K, filed with the SEC on June 13, 2024 — read the filing on EDGAR.

How asset managers voted at the CLOVER HEALTH INVESTMENTS CORP. 2023-2024 meeting

96 asset managers disclosed a vote on at least one CLOVER HEALTH INVESTMENTS CORP. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Carladenise Armbrister Edwards

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 2 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 942,172,343WITHHELD: 21,176,155
Details: description as filed, official tally, votes by 11 asset managers

Description as filed by funds: ELECTION OF DIRECTORS: Carladenise Armbrister Edwards

CLOVER HEALTH INVESTMENTS CORP.’s own tally for this item (“Elect Director: Carladenise Armbrister Edwards”): 942,172,343 for, 21,176,155 withheld, per its Form 8-K filed June 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Chelsea Clinton, Carladenise Armbrister Edwards and Vivek Garipalli were each elected to the Company's Board of Directors as Class III directors, to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 11 asset managers below reported 8,172,373 for, 182,197 withheld, 6,044 abstained.

FOR
FOR: 8,172,373ABSTAIN: 6,044WITHHOLD: 182,197
Largest asset managers voting on “ELECTION OF DIRECTORS: Carladenise Armbrister Edwards” at CLOVER HEALTH INVESTMENTS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard4,392,3170 00For
Charles Schwab3,100,2800 00For
Invesco403,1620 00For
Fidelity265,2550 00For
Voya00 0163,124Withhold
Blackstone Alternative Investment Funds00 016,600Withhold
BlackRock9,6730 00For
John Hancock00 6,0440Abstain
Nationwide00 01,916Withhold
State Street1,6860 00For
Victory Capital00 0557Withhold

Elect Director: Chelsea Clinton

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 2 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 937,120,902WITHHELD: 26,227,596
Details: description as filed, official tally, votes by 11 asset managers

Description as filed by funds: ELECTION OF DIRECTORS: Chelsea Clinton

CLOVER HEALTH INVESTMENTS CORP.’s own tally for this item (“Elect Director: Chelsea Clinton”): 937,120,902 for, 26,227,596 withheld, per its Form 8-K filed June 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Chelsea Clinton, Carladenise Armbrister Edwards and Vivek Garipalli were each elected to the Company's Board of Directors as Class III directors, to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified.”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 11 asset managers below reported 4,588,936 for, 3,765,634 withheld, 6,044 abstained.

FORWITHHOLD
FOR: 4,588,936ABSTAIN: 6,044WITHHOLD: 3,765,634
Largest asset managers voting on “ELECTION OF DIRECTORS: Chelsea Clinton” at CLOVER HEALTH INVESTMENTS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard4,392,3170 00For
Charles Schwab00 03,100,280Withhold
Invesco00 0403,162Withhold
Fidelity185,2600 079,995Mixed
Voya00 0163,124Withhold
Blackstone Alternative Investment Funds00 016,600Withhold
BlackRock9,6730 00For
John Hancock00 6,0440Abstain
Nationwide00 01,916Withhold
State Street1,6860 00For
Victory Capital00 0557Withhold

Elect Director: Vivek Garipalli

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 2 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 941,392,586WITHHELD: 21,955,912
Details: description as filed, official tally, votes by 11 asset managers

Description as filed by funds: ELECTION OF DIRECTORS: Vivek Garipalli

CLOVER HEALTH INVESTMENTS CORP.’s own tally for this item (“Elect Director: Vivek Garipalli”): 941,392,586 for, 21,955,912 withheld, per its Form 8-K filed June 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Chelsea Clinton, Carladenise Armbrister Edwards and Vivek Garipalli were each elected to the Company's Board of Directors as Class III directors, to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 11 asset managers below reported 8,170,687 for, 183,883 withheld, 6,044 abstained.

FOR
FOR: 8,170,687ABSTAIN: 6,044WITHHOLD: 183,883
Largest asset managers voting on “ELECTION OF DIRECTORS: Vivek Garipalli” at CLOVER HEALTH INVESTMENTS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard4,392,3170 00For
Charles Schwab3,100,2800 00For
Invesco403,1620 00For
Fidelity265,2550 00For
Voya00 0163,124Withhold
Blackstone Alternative Investment Funds00 016,600Withhold
BlackRock9,6730 00For
John Hancock00 6,0440Abstain
Nationwide00 01,916Withhold
State Street00 01,686Withhold
Victory Capital00 0557Withhold

Non-binding advisory vote to approve the compensation of the Company's Named Executive Officers for 2023

Calculated outcomeFund totals may overlapSECTION 14A SAY-ON-PAY VOTESPassed (calculated)

Combines 9 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 950,591,272AGAINST: 10,963,460

Prior year: 98.4% for (June 7, 2023 meeting) ▲ 0.5 pts

Details: description as filed, official tally, votes by 96 asset managers

Description as filed by funds: NON-BINDING ADVISORY PROPOSAL TO APPROVE THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS FOR 2023.

CLOVER HEALTH INVESTMENTS CORP.’s own tally for this item (“2. Non-binding advisory vote to approve the compensation of the Company's Named Executive Officers for 2023”): 950,591,272 for, 10,963,460 against, per its Form 8-K filed June 13, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 11 asset managers voting on “NON-BINDING ADVISORY PROPOSAL TO APPROVE THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS FOR 2023.” at CLOVER HEALTH INVESTMENTS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard4,392,3170 00For
Charles Schwab3,100,2800 00For
Invesco403,1620 00For
Fidelity265,2550 00For
Voya163,1240 00For
Blackstone Alternative Investment Funds16,6000 00For
BlackRock9,6730 00For
John Hancock6,0440 00For
Nationwide1,9160 00For
State Street1,6860 00For
Victory Capital5570 00For

Fund voting reports, all 11 managers: 8,360,614 for.

Institutional-manager reports: 90 asset managers voting on “NON-BINDING ADVISORY PROPOSAL TO APPROVE THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS FOR 2023.” at CLOVER HEALTH INVESTMENTS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock6,127,8050 00For
Renaissance5,411,8900 00For
JUPITER ASSET MANAGEMENT LTD4,525,0790 00For
Charles Schwab3,100,2800 00For
DE Shaw1,838,1400 00For
Two Sigma1,573,9660 00For
Allianz0786,333 00Against
GMT CAPITAL CORP0701,600 00Against
Connor, Clark & Lunn Investment Management Ltd.540,6630 00For
State Street518,5640 00For
Northern Trust443,1180 00For
Invesco414,4360 00For
UBS0274,212 00Against
Vanguard243,1310 00For
Legal & General Investment Management Ltd165,2790 00For
Voya163,1240 00For
Point72126,9100 00For
MELLON INVESTMENTS Corp121,9240 00For
Dimensional094,128 00Against
REGIONS FINANCIAL CORP91,5000 00For
GEODE CAPITAL MANAGEMENT, LLC89,6240 00For
JACOBS LEVY EQUITY MANAGEMENT, INC85,0610 00For
Aureus Asset Management, LLC079,000 00Against
AQR66,7250 00For
Arizona State Retirement System064,919 00Against

Institutional-manager reports, all 90 managers: 25,939,126 for, 2,086,374 against. Showing the 25 largest; every one is in the interactive database (link above).

Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 3 wordings of this item as funds reported it.

99.5% Approved · of votes cast

FOR 99.5%
FOR: 1,100,958,512AGAINST: 5,333,701

Prior year: 99.7% for (June 7, 2023 meeting) ▼ 0.2 pts

Details: description as filed, official tally, votes by 11 asset managers

Description as filed by funds: The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm.

CLOVER HEALTH INVESTMENTS CORP.’s own tally for this item (“3. Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2024”): 1,100,958,512 for, 5,333,701 against — passed, per its Form 8-K filed June 13, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.”
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 11 asset managers below reported 8,360,614 for.

FOR
FOR: 8,360,614
Largest asset managers voting on “The ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accoun” at CLOVER HEALTH INVESTMENTS CORP., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard4,392,3170 00For
Charles Schwab3,100,2800 00For
Invesco403,1620 00For
Fidelity265,2550 00For
Voya163,1240 00For
Blackstone Alternative Investment Funds16,6000 00For
BlackRock9,6730 00For
John Hancock6,0440 00For
Nationwide1,9160 00For
State Street1,6860 00For
Victory Capital5570 00For

Largest CLOVER HEALTH INVESTMENTS CORP. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 486,374,644 shares outstanding at the time of that meeting.

Fund voting reports: top CLOVER HEALTH INVESTMENTS CORP. shareholders by shares voted on “NON-BINDING ADVISORY PROPOSAL TO APPROVE THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS…”, 2023-2024
#Asset manager % of shares outstanding
1Vanguard 0.90%
2Charles Schwab 0.64%
3Invesco 0.08%
4Fidelity 0.05%
5Voya 0.03%
6Blackstone Alternative Investment Funds <0.01%
7BlackRock <0.01%
8John Hancock <0.01%
9Nationwide <0.01%
10State Street <0.01%
Institutional-manager reports: top CLOVER HEALTH INVESTMENTS CORP. shareholders by shares voted on “NON-BINDING ADVISORY PROPOSAL TO APPROVE THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS…”, 2023-2024
#Asset manager % of shares outstanding
1BlackRock 1.26%
2Renaissance 1.11%
3JUPITER ASSET MANAGEMENT LTD 0.93%
4Charles Schwab 0.64%
5DE Shaw 0.38%
6Two Sigma 0.32%
7Allianz 0.16%
8GMT CAPITAL CORP 0.14%
9Connor, Clark & Lunn Investment Management Ltd. 0.11%
10State Street 0.11%

Reported CLOVER HEALTH INVESTMENTS CORP. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

CLOVER HEALTH INVESTMENTS CORP. holdings and ownership disclosed for the 2023-2024 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
Vivek Garipalli88,817,153 18.26%Proxy statement (DEF 14A), table as of December 31, 2023
Entities affiliated with Vivek Garipalli83,584,543 17.19%Proxy statement (DEF 14A), table as of December 31, 2023
BlackRock30,394,942 6.25%Form 13F, quarter ended March 31, 2024
Vanguard Group23,060,008 4.74%Form 13F, quarter ended March 31, 2024
Renaissance Technologies11,396,600 2.34%Form 13F, quarter ended March 31, 2024
Geode Capital4,301,558 0.88%Form 13F, quarter ended March 31, 2024
D.E. Shaw3,718,177 0.76%Form 13F, quarter ended March 31, 2024
Charles Schwab3,094,125 0.64%Form 13F, quarter ended March 31, 2024
Andrew Toy2,689,623 0.55%Proxy statement (DEF 14A), table as of December 31, 2023
Two Sigma2,525,895 0.52%Form 13F, quarter ended March 31, 2024

Percentages above are of 486,374,644 shares outstanding, as reported by CLOVER HEALTH INVESTMENTS CORP. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At CLOVER HEALTH INVESTMENTS CORP.'s shareholder meeting held June 10, 2024, in the 2023-2024 proxy season, 96 asset managers reported votes on at least one of its 5 ballot items in their SEC Form N-PX filings, covering 267 separate fund positions. On the most widely held item on that ballot — NON-BINDING ADVISORY PROPOSAL TO APPROVE THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS… — FOR was 99% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: CLOVER HEALTH INVESTMENTS CORP.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 13, 2024.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CLOVER HEALTH INVESTMENTS CORP.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

CLOVER HEALTH INVESTMENTS CORP. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Cite this page

Proxy Votes Now, “CLOVER HEALTH INVESTMENTS (CLOV) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/clover-health-investments-corp/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.